The Queen’s Health Systems in Hawaii has opened the Queen’s Advanced Lung Institute, a facility on Hawai’i for the diagnosis and treatment of lung cancer.
Featuring a multi-disciplinary team and current technology, the institute will enable patients to be diagnosed, staged and treated in one location.
Go deeper with GlobalData
It is Hawaii’s largest robotic surgery centre for lung cancer treatment and will provide precision medicine tailored for each patient’s treatment.
Queen’s Health Systems Clinical Integration executive vice-president and chief physician executive Dr Whitney Limm said: “We are pleased to offer this type of service to our patients, all in an effort to reshape and lead Hawai’i’s vision in lung cancer care using an innovative approach to provide the highest level of comprehensive care.
“This highlights our commitment of ensuring the health and well-being of our community.”
By taking a ‘streamlined’ approach, the Queen’s Advanced Lung Institute aims to reduce the timeline of diagnosis to treatment from an average of eight weeks to less than four hours.
It has Hawaii’s first AI nodule detection programme, which is designed to enable the early diagnosis of lung cancer, as well as the state’s only multi-disciplinary lung nodule clinic.
The institute is also the first in Hawaii to use the ION Navigational platform, a fully robotic, minimally invasive procedure for the lung nodules evaluation.
Queen’s Thoracic Surgery Programme director Dr Taryne Imai said: “Hawaiʻi has ranked last in the nation for early diagnosis of lung cancer for three consecutive years, and our mission is to change that.
“The Queen’s Advanced Lung Institute is a game-changer for early detection and treatment for our community and offers hope for a cure.”
The Queen’s Health Systems has performed 650 biopsies and diagnosed 325 lung cancer cases over the last two years.
Last year, it acquired Wahiawa General Hospital, which has since been rebranded as The Queen’s Medical Center—Wahiawa.
